|
|||||
|
|
Identifying newly approved medications in Medicare claims data: a case study using tocilizumab |
|
| Authors: | Jeffrey R. Curtis Fenglong Xie Rui Chen Lang Chen Meredith L Kilgore James D. Lewis Huifeng Yun Jie Zhang Nicole C. Wright Elizabeth Delzell |
| Affiliation: | 1. University of Alabama at Birmingham, Division of Clinical Immunology and Rheumatology, , Birmingham, AL, USA;2. University of Alabama at Birmingham, Epidemiology, , Birmingham, AL, USA;3. School of Public Health, University of Alabama at Birmingham, Department of Health Care, Organization and Policy, , Birmingham, AL, USA;4. Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, , Philadelphia, PA, USA |
| Abstract: | |
| Keywords: | rheumatoid arthritis Medicare Part D biologics tocilizumab denosumab certolizumab linkage registry pharmacoepidemiology |